These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19818677)

  • 1. Perspectives of targeted mass spectrometry for protein biomarker verification.
    Hüttenhain R; Malmström J; Picotti P; Aebersold R
    Curr Opin Chem Biol; 2009 Dec; 13(5-6):518-25. PubMed ID: 19818677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualification and Verification of Protein Biomarker Candidates.
    Zhao Y; Brasier AR
    Adv Exp Med Biol; 2016; 919():493-514. PubMed ID: 27975232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.
    Shi T; Su D; Liu T; Tang K; Camp DG; Qian WJ; Smith RD
    Proteomics; 2012 Apr; 12(8):1074-92. PubMed ID: 22577010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted mass spectrometry approaches for protein biomarker verification.
    Meng Z; Veenstra TD
    J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
    Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
    J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
    Hüttenhain R; Choi M; Martin de la Fuente L; Oehl K; Chang CY; Zimmermann AK; Malander S; Olsson H; Surinova S; Clough T; Heinzelmann-Schwarz V; Wild PJ; Dinulescu DM; Niméus E; Vitek O; Aebersold R
    Mol Cell Proteomics; 2019 Sep; 18(9):1836-1850. PubMed ID: 31289117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
    Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry.
    Keshishian H; Burgess MW; Specht H; Wallace L; Clauser KR; Gillette MA; Carr SA
    Nat Protoc; 2017 Aug; 12(8):1683-1701. PubMed ID: 28749931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Candidate Biomarkers.
    Wiktorowicz JE; Soman KV
    Adv Exp Med Biol; 2016; 919():443-462. PubMed ID: 27975230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker validation by targeted mass spectrometry.
    McIntosh M; Fitzgibbon M
    Nat Biotechnol; 2009 Jul; 27(7):622-3. PubMed ID: 19587666
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted and Untargeted Proteomics Approaches in Biomarker Development.
    Sobsey CA; Ibrahim S; Richard VR; Gaspar V; Mitsa G; Lacasse V; Zahedi RP; Batist G; Borchers CH
    Proteomics; 2020 May; 20(9):e1900029. PubMed ID: 31729135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted proteomics: a bridge between discovery and validation.
    Harlan R; Zhang H
    Expert Rev Proteomics; 2014 Dec; 11(6):657-61. PubMed ID: 25348939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward an integrated pipeline for protein biomarker development.
    Drabovich AP; Martínez-Morillo E; Diamandis EP
    Biochim Biophys Acta; 2015 Jun; 1854(6):677-86. PubMed ID: 25218201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry.
    Ahn YH; Ji ES; Oh NR; Kim YS; Ko JH; Yoo JS
    J Proteomics; 2014 Jun; 106():221-9. PubMed ID: 24780727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to Clinical Proteomics.
    Wiktorowicz JE; Brasier AR
    Adv Exp Med Biol; 2016; 919():435-441. PubMed ID: 27975229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid verification of candidate serological biomarkers using gel-based, label-free multiple reaction monitoring.
    Tang HY; Beer LA; Barnhart KT; Speicher DW
    J Proteome Res; 2011 Sep; 10(9):4005-17. PubMed ID: 21726088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery.
    Shi T; Zhou JY; Gritsenko MA; Hossain M; Camp DG; Smith RD; Qian WJ
    Methods; 2012 Feb; 56(2):246-53. PubMed ID: 21925605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Chip/Chip/SRM platform using digital chip isoelectric focusing and LC-Chip mass spectrometry for enrichment and quantitation of low abundance protein biomarkers in human plasma.
    Rafalko A; Dai S; Hancock WS; Karger BL; Hincapie M
    J Proteome Res; 2012 Feb; 11(2):808-17. PubMed ID: 22098410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fit-for-purpose curated database application in mass spectrometry-based targeted protein identification and validation.
    Cheng K; Sloan A; McCorrister S; Babiuk S; Bowden TR; Wang G; Knox JD
    BMC Res Notes; 2014 Jul; 7():444. PubMed ID: 25011440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers.
    Whiteaker JR; Zhao L; Anderson L; Paulovich AG
    Mol Cell Proteomics; 2010 Jan; 9(1):184-96. PubMed ID: 19843560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.